BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16108002)

  • 1. Should the consensus guidelines' specific criteria for the diagnosis of invasive fungal infection be changed?
    de Pauw BE; Patterson TF
    Clin Infect Dis; 2005 Sep; 41 Suppl 6():S377-80. PubMed ID: 16108002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptoms and diagnosis of nosocomial fungal infections -- state-of-the-art.
    Donnelly JP
    Eur J Med Res; 2002 May; 7(5):192-9. PubMed ID: 12069911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.
    Segal BH; Almyroudis NG; Battiwalla M; Herbrecht R; Perfect JR; Walsh TJ; Wingard JR
    Clin Infect Dis; 2007 Feb; 44(3):402-9. PubMed ID: 17205448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive fungal infection in Ramathibodi Hospital: a ten-year autopsy review.
    Larbcharoensub N; Srisuma S; Ngernprasertsri T; Aroonroch R; Chongtrakool P; Santanirand P; Chirachariyavej T; Sirikulchayanonta V
    J Med Assoc Thai; 2007 Dec; 90(12):2630-7. PubMed ID: 18386713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early diagnosis of invasive fungal infections in hematooncological patients by serological methods].
    Rácil Z; Kocmanová I; Wagnerová B; Lengerová M; Mayer J
    Vnitr Lek; 2007 Sep; 53(9):990-9. PubMed ID: 18019671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical overview of clinical guidelines relating to invasive fungal infections.
    Sá MB; Zaragoza R
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S155-9. PubMed ID: 19013341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
    Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
    Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in invasive fungal infections, with emphasis on invasive aspergillosis.
    Erjavec Z; Kluin-Nelemans H; Verweij PE
    Clin Microbiol Infect; 2009 Jul; 15(7):625-33. PubMed ID: 19673973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral and fungal infections after liver transplantation--part II.
    Kusne S; Blair JE
    Liver Transpl; 2006 Jan; 12(1):2-11. PubMed ID: 16382451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiologic consequences of new approaches to managing hematologic malignancies.
    Blijlevens NM; Donnelly JP; de Pauw BE
    Rev Clin Exp Hematol; 2005 Dec; 9(2):E2. PubMed ID: 16864116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.
    Shi SH; Lu AW; Shen Y; Jia CK; Wang WL; Xie HY; Zhang M; Liang TB; Zheng SS
    Chin Med J (Engl); 2008 Apr; 121(7):625-30. PubMed ID: 18466683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
    Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing patterns and trends in systemic fungal infections.
    Richardson MD
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i5-i11. PubMed ID: 16120635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular and immunological methods applied in diagnosis of mycoses].
    Kuba K
    Wiad Parazytol; 2008; 54(3):187-97. PubMed ID: 19055059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of acute rheumatic fever diagnosis in a high-incidence population: a prospective study and proposed guidelines for diagnosis in Australia's Northern Territory.
    Ralph A; Jacups S; McGough K; McDonald M; Currie BJ
    Heart Lung Circ; 2006 Apr; 15(2):113-8. PubMed ID: 16574535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of yeasts in diabetic foot ulcer infection].
    Missoni EM; Kalenić S; Vukelić M; De Syo D; Belicza M; Kern J; Babić VV
    Acta Med Croatica; 2006; 60(1):43-50. PubMed ID: 16802571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
    Metcalf SC; Dockrell DH
    J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
    Castroagudín JF; Pontón C; Bustamante M; Otero E; Martínez J; Tomé S; Conde R; Segade FR; Delgado M; Brage A; Galbán C; Varo E
    Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
    Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
    Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive fungal infection--laboratory diagnosis and antifungal treatment.
    Shao PL; Huang LM; Hsueh PR
    J Microbiol Immunol Infect; 2006 Jun; 39(3):178-88. PubMed ID: 16783447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.